
UMass Lowell event highlights revenue potential of entrepreneurship, innovation programs
University of Massachusetts Lowell is behaving like a budding venture capitalist these days, supporting programs in entrepreneurship and innovation with an eye toward potential payoffs down the road. A recent example of the opportunities at hand: UMass Lowell secured $3.8 million earlier this year from its ownership stake in Anterios, a biotech startup driven by intellectual property created on campus. Anterios, which developed a topical version of Botox that can be applied on the skin rather than through needle injection, was sold to global pharmaceuticals company Allergan for $96 million in January.
(read more)